In multiple myeloma, PADI2 is the most up-regulated transcript in bone marrow mesenchymal stem cells, which may mediate the up-regulation of IL-6 expression by inducing histone citrullination, enabling tumor cells to acquire resistance to anti-tumor drugs (McNee et al., 2017). Here, PADI2 is linked to plasma cell myeloma.